Alyeska Investment Group’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-355,690
| Closed | -$2.37M | – | 812 |
|
|
2021
Q1 | $2.37M | Hold |
355,690
| – | – | 0.03% | 434 |
|
|
2020
Q4 | $1.88M | Sell |
355,690
-2,845
| -0.8% | -$15.1K | 0.03% | 371 |
|
|
2020
Q3 | $2.67M | Sell |
358,535
-30,068
| -8% | -$224K | 0.04% | 317 |
|
|
2020
Q2 | $2.86M | Buy |
+388,603
| New | +$2.86M | 0.04% | 317 |
|
|
2019
Q1 | – | Sell |
-177,135
| Closed | -$666K | – | 403 |
|
|
2018
Q4 | $666K | Sell |
177,135
-53,684
| -23% | -$202K | 0.01% | 288 |
|
|
2018
Q3 | $1.36M | Hold |
230,819
| – | – | 0.01% | 306 |
|
|
2018
Q2 | $1.31M | Buy |
230,819
+7,381
| +3% | +$41.8K | 0.01% | 353 |
|
|
2018
Q1 | $2.77M | Buy |
223,438
+48,438
| +28% | +$601K | 0.02% | 302 |
|
|
2017
Q4 | $2.12M | Buy |
+175,000
| New | +$2.12M | 0.02% | 309 |
|